TMDX Q2 2018 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M+30.6% YoY

Gross Profit

$1M40.4% margin

Operating Income

-$5M-176.9% margin

Net Income

-$6M-209.8% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+15.7%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$34,000

Balance Sheet

Total Assets

$51M

Total Liabilities

$44M

Stockholders' Equity

$7M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+30.6%
Gross Profit	$1M	$811,000	+45.4%
Operating Income	-$5M	-$6M	+9.7%
Net Income	-$6M	-$6M	-6.5%